VEGFA and oral cavity squamous cell carcinoma: In addition, MSCs-Exo could facilitate VEGF suppression and inhibit the growth of oral squamous cell carcinoma [81] and prostate cancer cells by preventing VEGF production and NF-κB signaling [82].